Good Laboratory Practice for Nonclinical Laboratory Studies
Document ID: FDA-2010-N-0548-0001
Comments
Total: 85
-
Anonymous - Comment
Posted : 12/21/2010 ID ：FDA-2010-N-0548-0002 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
AMU - Comment
Posted : 12/28/2010 ID ：FDA-2010-N-0548-0003 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Thomas Davis - Comment
Posted : 01/18/2011 ID ：FDA-2010-N-0548-0004 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Judith A Davis - Comment
Posted : 01/18/2011 ID ：FDA-2010-N-0548-0005 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
European Union GLP Working Group - Comment
Posted : 02/08/2011 ID ：FDA-2010-N-0548-0006 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Judith Anne Davis - Comment
Posted : 02/08/2011 ID ：FDA-2010-N-0548-0007 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Talecris Biotherapeutics, Incorporated - Comment
Posted : 02/08/2011 ID ：FDA-2010-N-0548-0008 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
LyChron, LLC - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0010 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Environmental Protection Agency (EPA) - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0011 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Experimental Pathology Laboratories, Inc. (EPL) - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0012 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
RLS Consulting - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0013 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Dale Cooper - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0014 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
AstraZeneca - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0015 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Strategic Toxicology Consulting LLC - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0016 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Department of the Army U.S. Army Medical Materiel Department Activity - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0017 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
German Society for Good Research Practice (DGGF e.V.) - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0018 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Pfizer Inc. - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0019 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Teva Pharmaceutical Ind. Ltd - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0020 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
GlaxoSmithKline - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0021 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Quality Associates Incorporated - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0022 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Bristol-Myers Squibb Company - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0023 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
sanofi-aventis - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0024 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Universidad de Navarra - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0025 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Organisation for Economic Cooperation and Development (OECD) - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0026 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
International Consortium for Innovation and Quality in Pharmaceutical Development - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0027 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
MPI Research - Comment
Posted : 02/18/2011 ID ：FDA-2010-N-0548-0028 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
USGS Upper Midwest Environmental Sciences Center - Comment
Posted : 02/23/2011 ID ：FDA-2010-N-0548-0029 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
USGS Upper Midwest Environmental Sciences Center - Comment
Posted : 02/23/2011 ID ：FDA-2010-N-0548-0030 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
Incyte Corporation - Comment
Posted : 02/23/2011 ID ：FDA-2010-N-0548-0031 Agency : FDA -
Feb 22,2011 11:59 PM ET
-
The University of Texas MD Anderson Cancer Center - Comment
Posted : 02/23/2011 ID ：FDA-2010-N-0548-0032 Agency : FDA -
Feb 22,2011 11:59 PM ET